Literature DB >> 20494656

Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.

Michael Maeng1, Peter Haubjerg Nielsen, Martin Busk, Leif Spange Mortensen, Steen Dalby Kristensen, Torsten Toftegaard Nielsen, Henning Rud Andersen.   

Abstract

In patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (pPCI), early reperfusion is believed to improve left ventricular systolic function and reduce mortality; however, long-term (>1 year) data are sparse. In the DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) study, 686 patients with ST-segment elevation myocardial infarction were treated with pPCI. Long-term mortality was obtained during 3 years of follow-up. We classified the patients according to the symptom-to-balloon time (<3, 3 to 5, and > or =5 hours). The groups were compared using a Cox proportional hazards regression model adjusted for confounding factors. The left ventricular systolic ejection fraction was estimated by echocardiography before discharge. Coronary flow was evaluated using the Thrombolysis In Myocardial Infarction score. Mortality did not differ between the 2 earliest symptom-to-balloon groups, and they were therefore combined into 1 group in the analysis of survival. Mortality was significantly increased for patients with a symptom-to-balloon time > or =5 hours (hazard ratio 2.36, 95% confidence interval 1.51 to 3.67, p <0.001), a difference that remained significant after controlling for confounding factors (adjusted hazard ratio 2.44, 95% confidence interval 1.31 to 4.54, p = 0.007). The symptom-to-balloon time was inversely associated with a left ventricular systolic ejection fraction of < or =40% (19.7% vs 22.8% vs 33.1%, p = 0.036), with the latter a major predictor of 3-year mortality in this cohort (hazard ratio 6.02, 95% confidence interval 3.68 to 9.85, p <0.001). A shorter symptom-to-balloon time was associated with greater rates of Thrombolysis In Myocardial Infarction 3 flow after pPCI (86.5% vs 80.9% vs 75.7%, p = 0.002). In conclusion, a shorter symptom-to-balloon time was associated with improved coronary flow, an increased likelihood of subsequent left ventricular systolic ejection fraction >40%, and greater 3-year survival in patients with ST-segment elevation myocardial infarction treated with pPCI. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494656     DOI: 10.1016/j.amjcard.2010.01.005

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.

Authors:  Tal Hasin; Yariv Gerber; Susan A Weston; Ruoxiang Jiang; Jill M Killian; Sheila M Manemann; James R Cerhan; Véronique L Roger
Journal:  J Am Coll Cardiol       Date:  2016-07-19       Impact factor: 24.094

2.  Community trends in the use and characteristics of persons with acute myocardial infarction who are transported by emergency medical services.

Authors:  Robert J Goldberg; Julie Lamusta; Chad Darling; Matthew DeWolf; Jane S Saczynski; Darleen Lessard; Jeanine Ward; Joel M Gore
Journal:  Heart Lung       Date:  2012-03-20       Impact factor: 2.210

3.  In-Hospital Tele-ECG Triage and Interventional Cardiologist Activation of the Infarct Team for STEMI Patients is Associated with Improved Late Clinical Outcomes.

Authors:  Kuan-Chun Chen; Wei-Hsian Yin; Mason Shing Young; Jeng Wei
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

4.  Diagnosis of acute serious illness: the role of point-of-care technologies.

Authors:  Gregory L Damhorst; Erika A Tyburski; Oliver Brand; Greg S Martin; Wilbur A Lam
Journal:  Curr Opin Biomed Eng       Date:  2019-09-16

5.  Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction.

Authors:  Karl Heinrich Scholz; Thomas Meyer; Björn Lengenfelder; Christian Vahlhaus; Jörn Tongers; Steffen Schnupp; Rainer Burckhard; Nicolas von Beckerath; Hans-Martin Grusnick; Andreas Jeron; Klaus Dieter Winter; Sebastian K G Maier; Michael Danner; Jürgen Vom Dahl; Stefan Neef; Stefan Stefanow; Tim Friede
Journal:  Open Heart       Date:  2021-05

Review 6.  An overview of PCI in the very elderly.

Authors:  Vimalraj Bogana Shanmugam; Richard Harper; Ian Meredith; Yuvaraj Malaiapan; Peter J Psaltis
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

7.  Impact of around-the-clock in-house cardiology fellow coverage on door-to-balloon time in an academic medical center.

Authors:  Luke C Kohan; Vijaiganesh Nagarajan; Michael A Millard; Michael J Loguidice; Nancy M Fauber; Ellen C Keeley
Journal:  Vasc Health Risk Manag       Date:  2017-04-18

8.  Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study.

Authors:  Yasuaki Takeji; Hiroki Shiomi; Takeshi Morimoto; Yusuke Yoshikawa; Ryoji Taniguchi; Yukiko Mutsumura-Nakano; Ko Yamamoto; Kyohei Yamaji; Junichi Tazaki; Eri Toda Kato; Hirotoshi Watanabe; Erika Yamamoto; Yugo Yamashita; Masayuki Fuki; Satoru Suwa; Moriaki Inoko; Teruki Takeda; Manabu Shirotani; Natsuhiko Ehara; Katsuhisa Ishii; Tsukasa Inada; Toshihiro Tamura; Tomoya Onodera; Eiji Shinoda; Takashi Yamamoto; Hiroki Watanabe; Hidenori Yaku; Kenji Nakatsuma; Hiroki Sakamoto; Kenji Ando; Yoshiharu Soga; Yutaka Furukawa; Yukihito Sato; Yoshihisa Nakagawa; Kazushige Kadota; Tatsuhiko Komiya; Kenji Minatoya; Takeshi Kimura
Journal:  BMJ Open       Date:  2021-03-31       Impact factor: 2.692

9.  Impact of Total Ischemic Time on Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction: Lost Time Is Never Found Again.

Authors:  Pradeep Kurmi; Vishwa D Tripathi; Sunil K Tripathi
Journal:  Cureus       Date:  2022-03-14

10.  Close, but not close enough.

Authors:  J Daemen
Journal:  Neth Heart J       Date:  2014-11       Impact factor: 2.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.